Received Nov 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
has failed to show an immune response (as verified by titer) after receiving multiple doses of a booster vaccine of MMR; This non-serious case was reported by a physician via call center representative and described the occurrence of therapy non-responder in a patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced therapy non-responder (Verbatim: has failed to show an immune response (as verified by titer) after receiving multiple doses of a booster vaccine of MMR). The outcome of the therapy non-responder was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 05-NOV-2025 The reporter would like information regarding recommendations for the patient who failed to show an immune response. The batch number was not provided and a request for this information has been made.
Test Name: serology test; Result Unstructured Data: (Test Result:had failed to show an immune response,Unit:unknown,Normal Low:,Normal High:)